Clinical laboratory services play a key role in early detection and treatment. Absent congressional action, these tests will face additional payment cuts, thwarting access and innovation. Tell Congress to #StopLabCuts and pass the #RESULTSAct this year: stoplabcuts.org.

Unless Congress intervenes, a fourth round of payment cuts may jeopardize patient access to critical laboratory services. Congress must pass the #RESULTSAct this year and #StopLabCuts: stoplabcuts.org.

Americans rely on lab tests for early detection, diagnosis, and treatment. But Medicare’s current payment system threatens access. Congress must act now. Support the #RESULTSAct to protect patient care and #StopLabCuts: stoplabcuts.org.

Over 30 national provider groups agree – it’s time for Congress to pass the #RESULTSAct to preserve and enhance patient access to critical laboratory services that inform the majority of healthcare decisions. Tell Congress to #StopLabCuts this year: StopLabCuts.org.

More than 30 leading provider groups support the #RESULTSAct, a long-term solution to #StopLabCuts. Congress must act now to protect access for the tens of millions of patients and providers who rely on laboratory tests for diagnosis, monitoring, and treatment: StopLabCuts.org.

Clinical laboratory testing can provide answers for patients with rare diseases and their families sooner, allowing them to move forward with confidence through treatment planning and disease management. The RESULTS Act will protect patient access to these critical tests.

Advanced clinical laboratory testing can help providers make decisions about whether their patients require chemotherapy as part of their breast cancer treatment. The RESULTS Act will ensure patients maintain access to timely, crucial laboratory testing.

Genomic testing arms providers with information to guide the best course of treatment for their patients, optimizing prescribing for patients on antidepressants. The RESULTS Act will support innovation in clinical laboratory testing that informs personalized care.

Clinical laboratory testing helps patients and providers make informed decisions, improving care and outcomes. Congress must pass the #RESULTSAct to protect access to essential testing.

Early detection matters. Blood-based biomarkers can help identify Alzheimer-related changes before symptoms appear. Protect access to innovative diagnostics by passing the #RESULTSAct.

Clinical laboratory tests can detect signs of cancer recurrence, helping doctors act earlier and improving outcomes for patients. Congress must pass the #RESULTSAct to protect access to these essential diagnostic tools.